172 related articles for article (PubMed ID: 38115701)
1. Transcription factor 12-mediated self-feedback regulatory mechanism is required in DUX4 fusion leukaemia.
Li Z; Jiang M; Wang J; Zhuo Z; Zhang S; Tan Y; Hu W; Zhang H; Meng G
Clin Transl Med; 2023 Dec; 13(12):e1514. PubMed ID: 38115701
[TBL] [Abstract][Full Text] [Related]
2. DNA crosslinking and recombination-activating genes 1/2 (RAG1/2) are required for oncogenic splicing in acute lymphoblastic leukemia.
Zhang H; Cheng N; Li Z; Bai L; Fang C; Li Y; Zhang W; Dong X; Jiang M; Liang Y; Zhang S; Mi J; Zhu J; Zhang Y; Chen SJ; Zhao Y; Weng XQ; Hu W; Chen Z; Huang J; Meng G
Cancer Commun (Lond); 2021 Nov; 41(11):1116-1136. PubMed ID: 34699692
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of DUX4/IGH-driven transactivation.
Dong X; Zhang W; Wu H; Huang J; Zhang M; Wang P; Zhang H; Chen Z; Chen SJ; Meng G
Leukemia; 2018 Jun; 32(6):1466-1476. PubMed ID: 29572508
[TBL] [Abstract][Full Text] [Related]
4. Long-read sequencing unveils IGH-DUX4 translocation into the silenced IGH allele in B-cell acute lymphoblastic leukemia.
Tian L; Shao Y; Nance S; Dang J; Xu B; Ma X; Li Y; Ju B; Dong L; Newman S; Zhou X; Schreiner P; Tseng E; Hon T; Ashby M; Li C; Easton J; Gruber TA; Zhang J
Nat Commun; 2019 Jun; 10(1):2789. PubMed ID: 31243274
[TBL] [Abstract][Full Text] [Related]
5. Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia.
Lilljebjörn H; Henningsson R; Hyrenius-Wittsten A; Olsson L; Orsmark-Pietras C; von Palffy S; Askmyr M; Rissler M; Schrappe M; Cario G; Castor A; Pronk CJ; Behrendtz M; Mitelman F; Johansson B; Paulsson K; Andersson AK; Fontes M; Fioretos T
Nat Commun; 2016 Jun; 7():11790. PubMed ID: 27265895
[TBL] [Abstract][Full Text] [Related]
6. Reproducible Bioinformatics Analysis Workflows for Detecting
Thomson AJ; Rehn JA; Heatley SL; Eadie LN; Page EC; Schutz C; McClure BJ; Sutton R; Dalla-Pozza L; Moore AS; Greenwood M; Kotecha RS; Fong CY; Yong ASM; Yeung DT; Breen J; White DL
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835427
[TBL] [Abstract][Full Text] [Related]
7. Monoallelic
Veiga DFT; Tremblay M; Gerby B; Herblot S; Haman A; Gendron P; Lemieux S; Zúñiga-Pflücker JC; Hébert J; Cohen JP; Hoang T
Front Immunol; 2022; 13():867443. PubMed ID: 35401501
[TBL] [Abstract][Full Text] [Related]
8. Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults.
Yasuda T; Tsuzuki S; Kawazu M; Hayakawa F; Kojima S; Ueno T; Imoto N; Kohsaka S; Kunita A; Doi K; Sakura T; Yujiri T; Kondo E; Fujimaki K; Ueda Y; Aoyama Y; Ohtake S; Takita J; Sai E; Taniwaki M; Kurokawa M; Morishita S; Fukayama M; Kiyoi H; Miyazaki Y; Naoe T; Mano H
Nat Genet; 2016 May; 48(5):569-74. PubMed ID: 27019113
[TBL] [Abstract][Full Text] [Related]
9.
Zaliova M; Potuckova E; Hovorkova L; Musilova A; Winkowska L; Fiser K; Stuchly J; Mejstrikova E; Starkova J; Zuna J; Stary J; Trka J
Haematologica; 2019 Jul; 104(7):1407-1416. PubMed ID: 30630977
[No Abstract] [Full Text] [Related]
10. Insights into IGH clonal evolution in BCP-ALL: frequency, mechanisms, associations, and diagnostic implications.
Darzentas F; Szczepanowski M; Kotrová M; Hartmann A; Beder T; Gökbuget N; Schwartz S; Bastian L; Baldus CD; Pál K; Darzentas N; Brüggemann M
Front Immunol; 2023; 14():1125017. PubMed ID: 37143651
[TBL] [Abstract][Full Text] [Related]
11. Identifying IGH disease clones for MRD monitoring in childhood B-cell acute lymphoblastic leukemia using RNA-Seq.
Li Z; Jiang N; Lim EH; Chin WHN; Lu Y; Chiew KH; Kham SKY; Yang W; Quah TC; Lin HP; Tan AM; Ariffin H; Yang JJ; Yeoh AE
Leukemia; 2020 Sep; 34(9):2418-2429. PubMed ID: 32099036
[TBL] [Abstract][Full Text] [Related]
12. DUX Hunting-Clinical Features and Diagnostic Challenges Associated with
Rehn JA; O'Connor MJ; White DL; Yeung DT
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 33007870
[No Abstract] [Full Text] [Related]
13. Clinical relevance of T-cell receptor delta gene rearrangements in childhood B-precursor cell acute lymphoblastic leukaemia.
Díaz MA; Garcia-Sanchez F; Vicario JL; Ramirez M; Balas A; Madero L
Br J Haematol; 1997 Nov; 99(2):308-13. PubMed ID: 9375746
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin heavy chain locus chromosomal translocations in B-cell precursor acute lymphoblastic leukemia: rare clinical curios or potent genetic drivers?
Dyer MJ; Akasaka T; Capasso M; Dusanjh P; Lee YF; Karran EL; Nagel I; Vater I; Cario G; Siebert R
Blood; 2010 Feb; 115(8):1490-9. PubMed ID: 20042721
[TBL] [Abstract][Full Text] [Related]
15. RNA binding protein IGF2BP1 synergizes with ETV6-RUNX1 to drive oncogenic signaling in B-cell Acute Lymphoblastic Leukemia.
Sharma G; Tran TM; Bansal I; Beg MS; Bhardwaj R; Bassi J; Tan Y; Jaiswal AK; Tso C; Jain A; Singh J; Chattopadhyay P; Singh A; Chopra A; Bakhshi S; Casero D; Rao DS; Palanichamy JK
J Exp Clin Cancer Res; 2023 Sep; 42(1):231. PubMed ID: 37670323
[TBL] [Abstract][Full Text] [Related]
16. CIC-DUX4 Chromatin Profiling Reveals New Epigenetic Dependencies and Actionable Therapeutic Targets in CIC-Rearranged Sarcomas.
Bakaric A; Cironi L; Praz V; Sanalkumar R; Broye LC; Favre-Bulle K; Letovanec I; Digklia A; Renella R; Stamenkovic I; Ott CJ; Nakamura T; Antonescu CR; Rivera MN; Riggi N
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38275898
[TBL] [Abstract][Full Text] [Related]
17. DUX4-r exerts a neomorphic activity that depends on GTF2I in acute lymphoblastic leukemia.
Campolungo D; Salomé M; Biferali B; Tascini AS; Gabellini D
Sci Adv; 2023 Sep; 9(37):eadi3771. PubMed ID: 37713484
[TBL] [Abstract][Full Text] [Related]
18. Differences in immunoglobulin heavy chain gene rearrangmeent patterns between bone marrow and blood samples in childhood precursor B-acute lymphoblastic leaukemia at diagnosis.
Beishuizen A; Verhoeven MA; Hählen K; van Wering ER; van Dongen JJ
Leukemia; 1993 Jun; 7(6):60-3. PubMed ID: 8315958
[TBL] [Abstract][Full Text] [Related]
19. Circ_0000388 Exerts Oncogenic Function in Cervical Cancer Cells by Regulating miR-337-3p/
Meng QH; Li Y; Kong C; Gao XM; Jiang XJ
Cancer Biother Radiopharm; 2021 Feb; 36(1):58-69. PubMed ID: 32119786
[No Abstract] [Full Text] [Related]
20. MicroRNA-211 Enhances the Oncogenicity of Carcinogen-Induced Oral Carcinoma by Repressing TCF12 and Increasing Antioxidant Activity.
Chen YF; Yang CC; Kao SY; Liu CJ; Lin SC; Chang KW
Cancer Res; 2016 Aug; 76(16):4872-86. PubMed ID: 27221705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
